SLED1 Promoting Cell Proliferation and Inhibiting Apoptosis in Acute Myeloid Leukemia: a Study
- 10 March 2023
- journal article
- research article
- Published by Springer Nature in Applied Biochemistry and Biotechnology
- Vol. 195 (11) , 6633-6652
Abstract
In this study, we aimed to explore long non-coding RNA (lncRNA) sustained low-efficiency dialysis (SLED1) correlated with Bcl-2 apoptosis pathway in acute myeloid leukemia (AML). This study further aimed to determine its role in the regulation of AML progression and its action as a potential biomarker for better prognosis. AML microarray profiles GSE97485 and probe annotation from the Gene Expression Omnibus (GEO) database from the National Center for Biotechnology Information (NCBI) were detected using the GEO2R tool (http://www.ncbi.nlm.nih.gov/geo/geo2r/). The expression of AML was downloaded from the TCGA database (http://cancergenome.nih.gov/). The statistical analysis of the database was processed with R software. Bioinformatic analysis found that lncRNA SLED1 is highly expressed in AML patients and is associated with poor prognosis. We found that the increased SLED1 expression levels in AML were significantly correlated with FAB classification, human race, and age. Our study has shown that upregulation of SLED1 promoted AML cell proliferation and inhibited cell apoptosis in vitro; RNA sequencing showed increased expression of BCL-2 and indicated that SLED1 might promote the development of AML by regulating BCL-2. Our results showed that SLED1 could promote the proliferation and inhibit the apoptosis of AML cells. SLED1 might promote the development of AML by regulating BCL-2, but the mechanism involved in the progression of AML is unclear. SLED1 plays an important role in AML progression, may be applied as a rapid and economical AML prognostic indicator to predict the survival of AML patients, and help guide experiments for potential clinical drag targets.Keywords
Funding Information
- China Scholarship Council (201906225042)
- The Youth Scientific Foundation of Qilu Hospital (QDKY2015QN10))
This publication has 37 references indexed in Scilit:
- Targeting mitochondria for cancer therapyEnvironmental and Molecular Mutagenesis, 2010
- Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNetBlood, 2010
- AML in older patients: Are we making progress?Best Practice & Research Clinical Haematology, 2009
- Age-Related Risk Profile and Chemotherapy Dose Response in Acute Myeloid Leukemia: A Study by the German Acute Myeloid Leukemia Cooperative GroupJournal of Clinical Oncology, 2009
- Deregulation of Signaling Pathways in Acute Myeloid LeukemiaSeminars in Oncology, 2008
- Epigenetic regulation of signal transducer and activator of transcription 3 in acute myeloid leukemiaLeukemia Research, 2008
- Rapid Identification of UCA1 as a Very Sensitive and Specific Unique Marker for Human Bladder CarcinomaClinical Cancer Research, 2006
- Age and acute myeloid leukemiaBlood, 2006
- Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeuticsCancer Cell, 2002
- The roles of FLT3 in hematopoiesis and leukemiaBlood, 2002